What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901).

Saved in:
Bibliographic Details
Title: What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901).
Authors: Robb WB; Department of Oesophageal and Gastric Surgery, Beaumont Hospital and the Royal College of Surgeons in Ireland, Ireland., Veziant J; CHU Lille, Departement of Digestive and Oncological Surgery, F-59000, Lille, France; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France. Electronic address: julie.veziant@chu-lille.fr., Dahan L; Department of Digestive Oncology, La Timone Hospital, Aix-Marseille University, Marseille, France., Mornex F; Department of Radiotherapy, Pierre-Bénite Hospital, Lyon, France., Barbier E; FFCD EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Dijon, France., D'Journo XB; Department of Thoracic Surgery, Hôpital Nord, Marseille, France., Manfredi S; FFCD EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Dijon, France; Department of Gastroenterology, University Hospital of Dijon, France., Boige V; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Jary M; Department of Surgical and Medical Oncology, University Hospital of Clermont-Ferrand, France., Christou N; Department of Digestive and Endocrine Surgery, CHU de Limoges, 2 Avenue Martin Luther King, 87000 Limoges, France; Laboratoire CAPTuR, INSERM U1308, Faculté de Médecine de Limoges, 2 Rue Du Docteur Marcland, 87000 Limoges, France., Lepage C; FFCD EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche-Comté, Dijon, France; Department of Gastroenterology, University Hospital of Dijon, France., Piessen G; CHU Lille, Departement of Digestive and Oncological Surgery, F-59000, Lille, France; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Corporate Authors: FFCD, SFRO, UNICANCER, GERCOR and the FREGAT working group-FRENCH
Source: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2025 Jul; Vol. 51 (7), pp. 109736. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2157
DOI:10.1016/j.ejso.2025.109736